FindTrial
Sign In

Acacia catechu to increase salivary flow in Dry Mouth Patients

â??Analysis of efficacy of Acacia catechu As a Secretagogue and Anti - Microbial agent in Management of Post Radiation induced Xerostomiaâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/023776
Enrollment
31
Registered
2020-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R682- Dry mouth, unspecified

Interventions

Intervention1: Acacia catechu: Used regularly as a thirst quencher in most parts of the country like kerala, Tamilnadu. No reported side effects. Dose : 300gm/day in 1 litre of drinking water Route of

Sponsors

PreethiA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Men and women diagnosed with head and neck carcinoma who undergoing radiotherapy as a treatment modality. 2.Age 20 to 70 years. 3.Post radiotherapy patients with a salivary flow rate

Exclusion criteria

Exclusion criteria: - Patients using xerostomia â?? relieving medications (Pilocarpine and Cevimeline) or therapies for Xerostomia (Mouthwash, Gum, and Toothpaste for Xerostomia).

Design outcomes

Primary

MeasureTime frame
Salivary flow rate. Anti-microbial activity against Streptococcus mutans and Lactobacillus acidophillusTimepoint: salivary flow rate and antimicrobial activity assessment checked as following intervals: 1. baseline value 2. mid intervention period at 4 weeks 3. post intervention period - 8 weeks—

Secondary

MeasureTime frame
QUALITY OF LIFE - QUESTIONNAIRETimepoint: 0 WEEKS AND AT 8 WEEKS—

Countries

India

Contacts

Public ContactPreethi Arunachalam

MDS

drramya268@gmail.com8825876700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026